The endothelium plays an important role in maintaining normal vascular function. Endothelial barrier dysfunction leading to increased permeability and vascular leakage is associated with several pathological conditions such as edema and sepsis. Thus, the development of drugs that improve endothelial barrier function is an active area of research. In this chapter, the current knowledge concerning the signaling pathways regulating endothelial barrier function is discussed with a focus on cyclic nucleotide second messengers (cAMP and cGMP) and cyclic nucleotide phosphodiesterases (PDEs). Both cAMP and cGMP have been shown to have differential effects on endothelial permeability in part due to the various effector molecules, crosstalk, and compartmentalization of cyclic nucleotide signaling. PDEs, by controlling the amplitude, duration, and localization of cyclic nucleotides, have been shown to play a critical role in regulating endothelial barrier function. Thus, PDEs are attractive drug targets for the treatment of disease states involving endothelial barrier dysfunction. © 2011 Springer-Verlag Berlin Heidelberg.
CITATION STYLE
Surapisitchat, J., & Beavo, J. A. (2011). Regulation of endothelial barrier function by cyclic nucleotides: The role of phosphodiesterases. Handbook of Experimental Pharmacology, 204, 193–210. https://doi.org/10.1007/978-3-642-17969-3_8
Mendeley helps you to discover research relevant for your work.